ANURAS2023-07-012023-09-30 ANURAS2023-07-012023-09-30 ANURAS2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member ANURAS2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member ANURAS2023-09-30 ANURAS2023-07-012023-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ANURAS2023-07-012023-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ANURAS2023-07-012023-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ANURAS2023-07-012023-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ANURAS2023-07-012023-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member ANURAS2023-07-012023-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member ANURAS2023-07-012023-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member ANURAS2023-07-012023-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543275 ANURAS NOTLISTED Anupam Rasayan India Limited Equity 2023-04-01 2024-03-31 2023-11-07 2023-11-01 INR Millions Half yearly 09:08:00 10:25:00 2023-11-07 2023-11-07 true Cash Flow Indirect Not applicable Single segment The Company operates in one revenue segment. i.e. Manufacturing of industrial chemicals. 2023-07-01 2023-09-30 Unaudited Consolidated 3921479000.00 34620000.00 3956099000.00 1872329000.00 0.00 -246992000.00 185029000.00 204255000.00 198493000.00 1036334000.00 3249448000.00 706651000.00 0.00 706651000.00 138821000.00 80912000.00 219733000.00 0.00 486918000.00 0.00 0.00 0.00 0.00 486918000.00 -5788000.00 481130000.00 406859000.00 80056000.00 400554000.00 80572000.00 1076052000.00 10 3.78 3.77 0.00 0.00 3.78 3.77 [1] The above Consoliated financial results for the quarter and half year ended September 30, 2023 have been prepared by the Company in accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (as amended) and were reviewed by the Audit Committee of the Board and thereafter were approved and taken on record by the Board of Directors in their meeting held on November 7, 2023. [2] Based on the management approach as defined in Ind AS 108 - Operating Segments, the Chief Operating Decision Maker (CODM) evaluates the company's performance and allocates resources based on an analysis of various performance indicators of business segment/s in which the company operates. The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals which the management and CODM recognise as the sole business segment. Hence, disclosure of segment-wise information is not required and accordingly not provided. [3] Out of total proceeds of Qualified Institutional Placement (QIP) INR 4,999.90 millions, INR 1,562.90 million has been utilised for Capex projects, general corporate purpose and INR 313.00 millions for Issue related expenses upto September 30, 2023 as per object of QIP as per Placement Documents filed with Securities and Exchange Board of India (SEBI) on October 03, 2022 and balance proceeds of INR 3,124.00 millions are lying with Bank Accounts and Fixed Deposits with Banks. [4] The Board of Directors have declared an interim dividend of INR 0.5/- @ 5% per Equity Share of face value of INR 10/- each. [5] The figures of the previous period have been re-grouped / rearranged and / or recasted wherever considered necessary. Single segment 2023-04-01 2023-09-30 Unaudited Consolidated 7785389000.00 158339000.00 7943728000.00 4170000000.00 0.00 -914444000.00 371164000.00 382304000.00 385284000.00 2069760000.00 6464068000.00 1479660000.00 0.00 1479660000.00 297041000.00 173172000.00 470213000.00 0.00 1009447000.00 0.00 0.00 0.00 0.00 1009447000.00 -1650000.00 1007797000.00 792903000.00 216544000.00 790737000.00 217061000.00 1076052000.00 10 7.36 7.35 0.00 0.00 7.36 7.35 Other Expenses 1036334000.00 Other Expenses 2069760000.00 1523252000.00 13069666000.00 2958343000.00 0.00 1232048000.00 183706000.00 0.00 0.00 0.00 14193000.00 0.00 94369000.00 1244371000.00 1352933000.00 0.00 743797000.00 19540493000.00 10107778000.00 839171000.00 6352743000.00 2337245000.00 1651309000.00 24865000.00 199222000.00 11404555000.00 0.00 1373621000.00 22885954000.00 0.00 0.00 42426447000.00 1076152000.00 23315146000.00 24391298000.00 25914550000.00 3600948000.00 0.00 0.00 3600948000.00 10583000.00 933461000.00 0.00 426700000.00 4971692000.00 7043591000.00 3573462000.00 480058000.00 11097111000.00 165759000.00 195676000.00 81659000.00 0.00 11540205000.00 0.00 0.00 16511897000.00 42426447000.00 381985000.00 -794250000.00 -2375552000.00 0.00 19430000.00 0.00 0.00 119165000.00 0.00 480552000.00 0.00 0.00 0.00 385284000.00 0.00 0.00 0.00 0.00 0.00 -31472000.00 0.00 2898000.00 3628000.00 0.00 0.00 0.00 0.00 -36274000.00 0.00 -1850402000.00 -370742000.00 0.00 0.00 0.00 286260000.00 0.00 -657002000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 39263000.00 2630285000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2898000.00 0.00 1571457000.00 0.00 -1016667000.00 0.00 0.00 0.00 0.00 0.00 0.00 31742000.00 0.00 2769209000.00 0.00 0.00 81247000.00 226034000.00 360841000.00 0.00 0.00 2132829000.00 459160000.00 0.00 459160000.00 1878085000.00 2337245000.00 Gain/(loss) on remeasurements of the defined benefits plan 3313000.00 Income tax (expense)/income on remeasurements of the defined benefits plan -928000.00 Gain/(loss) on remeasurements of the defined benefits plan 1936000.00 Income tax (expense)/income on remeasurements of the defined benefits plan -527000.00 2385000.00 1409000.00 0.00 0.00 Effective portion of gain/(loss) on hedging instruments in a cash flow hedge -11531000.00 Income tax (expense)/income on effective portion of gain/(loss) on hedging instruments in a cash flow hedge 3358000.00 Effective portion of gain/(loss) on hedging instruments in a cash flow hedge -4315000.00 Income tax (expense)/income on effective portion of gain/(loss) on hedging instruments in a cash flow hedge 1256000.00 -8173000.00 -3059000.00 0.00 0.00